Walleye Capital
CVAC

Walleye Capital’s CureVac CVAC Stock Holding History

Walleye Capital’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-187,872
Closed -$639K – 5388
2024
Q2 		$639K Buy
187,872
+177,139
+1,650% +$579K ﹤0.01% 3284
2024
Q1 		$32.5K Sell
10,733
-755,582
-99% -$2.65M ﹤0.01% 4802
2023
Q4 		$3.23M Buy
766,315
+369,685
+93% +$2.01M 0.01% 1420
2023
Q3 		$2.71M Buy
+396,630
New +$3.5M 0.01% 1496

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's CVAC Position: Q3 2024 in Review

Walleye Capital sold out of CureVac (CVAC) in Q3 2024, closing a stake of 187,872 shares — an estimated $639K sold.

Walleye Capital first reported a position in CVAC in Q3 2023 and held it in 4 quarters. The position peaked at $3.23M in Q4 2023. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Walleye Capital reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Walleye Capital sold 187,872 CureVac shares in Q3 2024, an estimated $639K.
  • Walleye Capital first reported a position in CureVac in Q3 2023 and held it in 4 quarters.
  • Walleye Capital's CureVac position peaked at $3.23M in Q4 2023.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.